STAAR Surgical Market Cap 2010-2025 | STAA
STAAR Surgical market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. STAAR Surgical market cap as of June 06, 2025 is $0.86B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.862B | $0.314B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $89.030B | 21.50 |
| Becton Dickinson (BDX) | United States | $49.018B | 12.14 |
| Cardinal Health (CAH) | United States | $36.785B | 19.26 |
| Labcorp (LH) | United States | $21.105B | 17.12 |
| Straumann Holding AG (SAUHY) | Switzerland | $20.511B | 0.00 |
| West Pharmaceutical Services (WST) | United States | $15.704B | 32.92 |
| Cooper (COO) | United States | $14.235B | 18.34 |
| Align Technology (ALGN) | United States | $13.066B | 25.94 |
| Henry Schein (HSIC) | United States | $8.578B | 14.71 |
| Merit Medical Systems (MMSI) | United States | $5.627B | 27.20 |
| DENTSPLY SIRONA (XRAY) | United States | $3.169B | 9.46 |
| CONMED (CNMD) | United States | $1.752B | 13.11 |
| Lifevantage (LFVN) | United States | $0.156B | 16.08 |
| Pro-Dex (PDEX) | United States | $0.138B | 15.08 |